The efficacy and safety of antibodies targeting PD-1 for treatment in advanced esophageal cancer: A systematic review and meta-analysis.

Lu, Yao; Guan, Lulu; Xu, Mengli; Wang, Feng

Lu, Yao; Guan, Lulu; Xu, Mengli; Wang, Feng.

Afiliação

Lu Y; Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P R China.
Guan L; Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P R China.
Xu M; Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P R China.
Wang F; Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P R China. Electronic address: zzuwangfeng@zzu.edu.cn.

Transl Oncol ; 14(6): 101083, 2021 Jun.

Article em En | MEDLINE | ID: mdl-33784583

Palavras-chave

Chemotherapy; Esophageal cancer; Immunotherapy; Meta-analysis; PD-1

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Transl Oncol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google